Clinical trials design: protocols and endpoints

Area of Science:

• Urology
• Clinical Trial Design
• Pharmacoeconomics

Background:

• A significant increase in clinical trials for erectile dysfunction (ED) treatments has occurred over the past decade.
• Previous reviews have addressed ED trial design and conduct, with a focus on symptomatic improvement.

Purpose of the Study:

• To expand the analysis of ED clinical trials beyond symptomatic improvement to encompass community patient management.
• To review common features and objectives of ED clinical trials, including regulatory, promotional, and surveillance-driven studies.

Main Methods:

• Analysis of clinical trial designs for erectile dysfunction agents.
• Focus on regulatory-standard or 'pivotal' studies.
• Consideration of trials for concept testing, post-marketing surveillance, and commercial reasons.

Main Results:

• Trial design is influenced by study objectives, such as regulatory approval, concept testing, or marketing.
• Pivotal studies are a major focus in ED clinical trial analysis.
• The scope of ED trials extends to broader patient management in the community.

Conclusions:

• Clinical trial design for erectile dysfunction must consider diverse objectives beyond symptomatic relief.
• A comprehensive understanding of trial design is crucial for effective ED patient management.
• Future research should encompass the full spectrum of ED trial applications.